Published Date: 23 Apr 2025
Roughly one in 14 people with lower-risk myelodysplastic syndromes (LR-MDS) have an infection in the first year after diagnosis, according to a study published online April 10 in Haematologica.
Read Full News1.
Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.
2.
Treatment of Oligometastatic EGFR-Mutant Lung Cancer
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Team finds broken 'brake' on cancer mutation machine.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Tremelimumab: A Potential Breakthrough in Cancer Treatment
2.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
3.
Progressive Strategies in Oncology and Patient Outcomes
4.
Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options
5.
Essential Applications in Oncology in Daily Practice
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Updates on the First Line Management of ALK+ NSCLC
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation